Paper37556044
Cebranopadol for the Treatment of Chronic Pain.
Edinoff AN and 10 others. Curr Pain Headache Rep, 2023. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Cebranopadol for the Treatment of Chronic Pain. Papers, record 37556044. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37556044
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chronic Pain | Major topic |
| Humans | |
| Quality of Life | |
| Morphine | |
| Indoles | |
| Analgesics, Opioid | |
| Nociceptin Receptor | |
| Randomized Controlled Trials as Topic | |
| Clinical Trials, Phase II as Topic | |
| Spiro Compounds |
Source PubMed
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26748087 | Common Brain Mechanisms of Chronic Pain and Addiction. | Neuron | 2016 | https://conductscience.org/library/papers/26748087 | PubMed |
| 2 | 19889986 | Brain gray matter decrease in chronic pain is the consequence and not the cause of pain. | J Neurosci | 2009 | https://conductscience.org/library/papers/19889986 | PubMed |
| 3 | 27324708 | Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. | BMJ Open | 2016 | https://conductscience.org/library/papers/27324708 | PubMed |
| 4 | 25248647 | Cebranopadol: a first in-class example of a nociceptin/orphanin FQ receptor and opioid receptor agonist. | Br J Anaesth | 2015 | https://conductscience.org/library/papers/25248647 | PubMed |
| 5 | 30983589 | Transition from acute to chronic pain after surgery. | Lancet | 2019 | https://conductscience.org/library/papers/30983589 | PubMed |
| 6 | 24762001 | Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists. | Br J Pharmacol | 2014 | https://conductscience.org/library/papers/24762001 | PubMed |
| 7 | 15561393 | Opioids in chronic non-cancer pain: systematic review of efficacy and safety. | Pain | 2004 | https://conductscience.org/library/papers/15561393 | PubMed |
| 8 | 22607834 | The economic costs of pain in the United States. | J Pain | 2012 | https://conductscience.org/library/papers/22607834 | PubMed |
| 9 | 25575710 | Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. | Lancet Neurol | 2015 | https://conductscience.org/library/papers/25575710 | PubMed |
| 10 | 26028573 | Estimates of pain prevalence and severity in adults: United States, 2012. | J Pain | 2015 | https://conductscience.org/library/papers/26028573 | PubMed |
| 11 | 26529271 | Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel. | Pain | 2016 | https://conductscience.org/library/papers/26529271 | PubMed |
| 12 | 36045694 | The Ramifications of Opioid Utilization and Outcomes of Alternative Pain Control Strategies for Total Knee Arthroplasties. | Orthop Rev (Pavia) | 2022 | https://conductscience.org/library/papers/36045694 | PubMed |
| 13 | 30531478 | Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study. | J Clin Psychopharmacol | 2019 | https://conductscience.org/library/papers/30531478 | PubMed |
| 14 | 29071457 | Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain. | Inflammopharmacology | 2018 | https://conductscience.org/library/papers/29071457 | PubMed |
| 15 | 16774457 | Differential diagnosis: nociceptive and neuropathic pain. | Am J Manag Care | 2006 | https://conductscience.org/library/papers/16774457 | PubMed |
| 16 | 24590861 | Chemotherapy-induced peripheral neurotoxicity: a critical analysis. | CA Cancer J Clin | 2013 | https://conductscience.org/library/papers/24590861 | PubMed |
| 17 | 28919117 | Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. | Lancet | 2017 | https://conductscience.org/library/papers/28919117 | PubMed |
| 18 | 10334273 | Pain: an overview. | Lancet | 1999 | https://conductscience.org/library/papers/10334273 | PubMed |
| 19 | 36118983 | Opioids in Urology: How Well Are We Preventing Opioid Dependence and How Can We Do Better? | Health Psychol Res | 2022 | https://conductscience.org/library/papers/36118983 | PubMed |
| 20 | 23794652 | Neuropathic pain in cancer. | Br J Anaesth | 2013 | https://conductscience.org/library/papers/23794652 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42420592 | Structural basis for dual targeting of μ-opioid and nociceptin/orphanin FQ receptors by Cebranopadol. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42420592 | PubMed |
| 40033110 | GPCR drug discovery: new agents, targets and indications. | Nat Rev Drug Discov | 2025 | https://conductscience.org/library/papers/40033110 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37556044
GET https://conductscience.org/api/papers/v1/37556044/references?page=2